1226549-45-6

Basic information

• Product Name: N-[3-(6-phenyl-4-{[(1R)-1-phenylethyl]amino}furo[2,3-d]pyrimidin-5-yl)phenyl]prop-2-enamide
• CAS NO: 1226549-45-6
• Molecular Weight: 460.535
• Mol File: 1226549-45-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-[3-(6-phenyl-4-{[(1R)-1-phenylethyl]amino}furo[2,3-d]pyrimidin-5-yl)phenyl]prop-2-enamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[3-(6-phenyl-4-{[(1R)-1-phenylethyl]amino}furo[2,3-d]pyrimidin-5-yl)phenyl]prop-2-enamide(1226549-45-6)
• EPA Substance Registry System: N-[3-(6-phenyl-4-{[(1R)-1-phenylethyl]amino}furo[2,3-d]pyrimidin-5-yl)phenyl]prop-2-enamide(1226549-45-6)

Safety Data

• Hazardous Substances Data: 1226549-45-6(Hazardous Substances Data)

Upstream product

• 814-68-6 acryloyl chloride 
• 1073135-81-5 5-bromo-4-chloro-6-phenylfuro[2,3-d]pyrimidine 

Relevant articles and documents

Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer

Epidermal growth factor receptor (EGFR)-targeted therapy in non-small cell lung cancer represents a breakthrough in the field of precision medicine. Previously, we have identified a lead compound, furanopyrimidine 2, which contains a (S)-2-phenylglycinol